Get access to all handy features included in the IVIS website
- Get unlimited access to books, proceedings and journals.
- Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
- Bookmark your favorite articles in My Library for future reading.
- Save future meetings and courses in My Calendar and My e-Learning.
- Ask authors questions and read what others have to say.
Results of a pharmacokinetic-based intravenous amiodarone treatment in horses with chronic atrial fibrillation
D. De Clercq 1, G. Van Loon 1, K...
Get access to all handy features included in the IVIS website
- Get unlimited access to books, proceedings and journals.
- Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
- Bookmark your favorite articles in My Library for future reading.
- Save future meetings and courses in My Calendar and My e-Learning.
- Ask authors questions and read what others have to say.
Read
La fibrillation auriculaire est une des plus importantes arythmies connue chez le cheval. Les symptômes sont entre autres une intolérance à l’exercice, une épistaxis, une respiration renforcée et une syncope. Des chevaux traités avec succès peuvent retrouver leur performance initiale. Le traitement standard pour le cheval, basé sur l’utilisation de la quinidine sulfate, peut donner beaucoup d’effets secondaires cardiaque et non cardiaque. Un traitement d’amiodarone (AD) est souvent utilisé pour soigner la fibrillation auriculaire chez l’être humain. Ce médicament a également été utilisé pour traiter cette arythmie chez le cheval1 ...
Get access to all handy features included in the IVIS website
- Get unlimited access to books, proceedings and journals.
- Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
- Bookmark your favorite articles in My Library for future reading.
- Save future meetings and courses in My Calendar and My e-Learning.
- Ask authors questions and read what others have to say.
About
Affiliation of the authors at the time of publication
1 Department of Large Animal Internal Medicine, 2 Department of Pharmacology, Toxicology, Biochemistry and Organ Physiology, Faculty of Veterinary Medicine 3 Department of Cardiology, University Hospital Ghent, Ghent University, Belgium
Comments (0)
Ask the author
0 comments